La maladie de Parkinson au Canada (serveur d'exploration) - Curation (Ncbi)

Index « Keywords » - entrée « Mice, Inbred C57BL »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Mice, Inbred BALB C < Mice, Inbred C57BL < Mice, Inbred NOD  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 52.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000106 (2000) S. Callier [Canada] ; M. Morissette ; M. Grandbois ; T. Di PaoloStereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice.
000155 (2001) F. Calon [Canada] ; N. Lavertu ; A M Lemieux ; M. Morissette ; M. Goulet ; R. Grondin ; P J Blanchet ; P J Bédard ; T. Di PaoloEffect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter.
000296 (2003) Pepijn Van Den Munckhof [Canada] ; Kelvin C. Luk ; Line Ste-Marie ; Jane Montgomery ; Pierre J. Blanchet ; Abbas F. Sadikot ; Jacques DrouinPitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons.
000305 (2003) Stephen J. Crocker [Canada] ; Patrice D. Smith ; Vernice Jackson-Lewis ; Wiplore R. Lamba ; Shawn P. Hayley ; Erich Grimm ; Steve M. Callaghan ; Ruth S. Slack ; Edon Melloni ; Serge Przedborski ; George S. Robertson ; Hymie Anisman ; Zul Merali ; David S. ParkInhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease.
000365 (2003) Patrice D. Smith [Canada] ; Stephen J. Crocker [Canada] ; Vernice Jackson-Lewis ; Kelly L. Jordan-Sciutto [États-Unis] ; Shawn Hayley [Canada] ; Matthew P. Mount [Canada] ; Michael J. O'Hare [Canada] ; Steven Callaghan [Canada] ; Ruth S. Slack [Canada] ; Serge Przedborski [États-Unis] ; Hymie Anisman [Canada] ; David S. Park [Canada]Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease
000372 (2003) Jackalina Van Kampen [Canada] ; Harold Robertson ; Theo Hagg ; Robert DrobitchNeuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease.
000519 (2005) Raymond H. Kim [Canada] ; Patrice D. Smith [Canada] ; Hossein Aleyasin [Canada] ; Shawn Hayley [Canada] ; Matthew P. Mount [Canada] ; Scott Pownall [Canada] ; Andrew Wakeham [Canada] ; Annick J. You-Ten [Canada] ; Suneil K. Kalia [Canada] ; Patrick Horne [Canada] ; David Westaway [Canada] ; Andres M. Lozano [Canada] ; Hymie Anisman [Canada] ; David S. Park [Canada] ; Tak W. Mak [Canada]Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress
000572 (2005) Kelly K. Meissner [Canada] ; David L. Kirkham ; Laurie C. DoeringTransplants of neurosphere cell suspensions from aged mice are functional in the mouse model of Parkinson's.
000581 (2005) Veronica Hirsch-Reinshagen [Canada] ; Luis F. Maia ; Braydon L. Burgess ; Jean-Francois Blain ; Kathryn E. Naus ; Sean A. Mcisaac ; Pamela F. Parkinson ; Jennifer Y. Chan ; Gavin H. Tansley ; Michael R. Hayden ; Judes Poirier ; William Van Nostrand ; Cheryl L. WellingtonThe absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease.
000592 (2006) Pepijn Van Den Munckhof [Canada] ; François Gilbert ; Michel Chamberland ; Daniel Lévesque ; Jacques DrouinStriatal neuroadaptation and rescue of locomotor deficit by L-dopa in aphakia mice, a model of Parkinson's disease.
000662 (1991) W G Tatton [Canada] ; C E GreenwoodRescue of dying neurons: a new action for deprenyl in MPTP parkinsonism.
000674 (2006) Michel St-Hilaire [Canada] ; Emmanuelle Bourhis ; Daniel Lévesque ; Claude RouillardImpaired behavioural and molecular adaptations to dopamine denervation and repeated L-DOPA treatment in Nur77-knockout mice.
000681 (2007) Haoran Wang [Canada] ; Mary X. Gao ; Linda Li ; Bin Wang ; Naohiro Hori ; Kenzo SatoIsolation, expression, and characterization of the human ZCRB1 gene mapped to 12q12.
000723 (2007) Anne M. Landau [Canada] ; Edouard Kouassi ; Rosmarie Siegrist-Johnstone ; Julie DesbaratsProteasome inhibitor model of Parkinson's disease in mice is confounded by neurotoxicity of the ethanol vehicle.
000746 (2007) Matthew P. Mount [Canada] ; Arman Lira ; David Grimes ; Patrice D. Smith ; Sylvie Faucher ; Ruth Slack ; Hymie Anisman ; Shawn Hayley ; David S. ParkInvolvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons.
000785 (2007) Dianbo Qu [Canada] ; Juliet Rashidian ; Matthew P. Mount ; Hossein Aleyasin ; Mohammad Parsanejad ; Arman Lira ; Emdadul Haque ; Yi Zhang ; Steve Callaghan ; Mireille Daigle ; Maxime W C. Rousseaux ; Ruth S. Slack ; Paul R. Albert ; Inez Vincent ; John M. Woulfe ; David S. ParkRole of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease.
000A71 (2009) Dirk W. Luchtman [Canada] ; Di Shao ; Cai SongBehavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease.
000D42 (2010) Qingjia Meng [Canada] ; Dirk W. Luchtman ; Bouchaib El Bahh ; Jeffrey A. Zidichouski ; Jun Yang ; Cai SongEthyl-eicosapentaenoate modulates changes in neurochemistry and brain lipids induced by parkinsonian neurotoxin 1-methyl-4-phenylpyridinium in mouse brain slices.
001002 (2012) Maria Xilouri [Grèce] ; Elli Kyratzi ; Pothitos M. Pitychoutis ; Zoi Papadopoulou-Daifoti ; Celine Perier ; Miquel Vila ; Matina Maniati ; Ayse Ulusoy ; Deniz Kirik ; David S. Park ; Keiji Wada ; Leonidas StefanisSelective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system.
001020 (2012) Jesse R. Mclean [États-Unis] ; Penelope J. Hallett ; Oliver Cooper ; Michael Stanley ; Ole IsacsonTranscript expression levels of full-length alpha-synuclein and its three alternatively spliced variants in Parkinson's disease brain regions and in a transgenic mouse model of alpha-synuclein overexpression.
001081 (1990) M N Hassan [Canada] ; J H Thakar ; J D GrimesBehavioral and biochemical effects of 4-phenylpyridine, 2-phenylpyridine, and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in rodents.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Mice, Inbred C57BL" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Mice, Inbred C57BL" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Mice, Inbred C57BL
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022